TY - JOUR
T1 - Cardiovascular Disease Guideline Adherence
T2 - An RCT Using Practice Facilitation
AU - Shelley, Donna R.
AU - Gepts, Thomas
AU - Siman, Nina
AU - Nguyen, Ann M.
AU - Cleland, Charles
AU - Cuthel, Allison M.
AU - Rogers, Erin S.
AU - Ogedegbe, Olugbenga
AU - Pham-Singer, Hang
AU - Wu, Winfred
AU - Berry, Carolyn A.
N1 - Publisher Copyright:
© 2020 American Journal of Preventive Medicine
PY - 2020/5
Y1 - 2020/5
N2 - Introduction: Practice facilitation is a promising practice transformation strategy, but further examination of its effectiveness in improving adoption of guidelines for multiple cardiovascular disease risk factors is needed. The objective of the study is to determine whether practice facilitation is effective in increasing the proportion of patients meeting the Million Hearts ABCS outcomes: (A) aspirin when indicated, (B) blood pressure control, (C) cholesterol management, and (S) smoking screening and cessation intervention. Study design: The study used a stepped-wedge cluster RCT design with 4 intervention waves. Data were extracted for 13 quarters between January 1, 2015 and March 31, 2018, which encompassed the control, intervention, and follow-up periods for all waves, and analyzed in 2019. Setting/participants: A total of 257 small independent primary care practices in New York City were randomized into 1 of 4 waves. Intervention: The intervention consisted of practice facilitators conducting at least 13 practice visits over 1 year, focused on capacity building and implementing system and workflow changes to meet cardiovascular disease care guidelines. Main outcome measures: The main outcomes were the Million Hearts’ ABCS measures. Two additional measures were created: (1) proportion of tobacco users who received a cessation intervention (smokers counseled) and (2) a composite measure that assessed the proportion of patients meeting treatment targets for A, B, and C (ABC composite). Results: The S measure improved when comparing follow-up with the control period (incidence rate ratio=1.152, 95% CI=1.072, 1.238, p<0.001) and when comparing follow-up with intervention (incidence rate ratio=1.060, 95% CI=1.013, 1.109, p=0.007). Smokers counseled improved when comparing the intervention period with control (incidence rate ratio=1.121, 95% CI=1.037, 1.211, p=0.002). Conclusions: Increasing the impact of practice facilitation programs that target multiple risk factors may require a longer, more intense intervention and greater attention to external policy and practice context. Trial registration: This study is registered at www.clinicaltrials.gov NCT02646488.
AB - Introduction: Practice facilitation is a promising practice transformation strategy, but further examination of its effectiveness in improving adoption of guidelines for multiple cardiovascular disease risk factors is needed. The objective of the study is to determine whether practice facilitation is effective in increasing the proportion of patients meeting the Million Hearts ABCS outcomes: (A) aspirin when indicated, (B) blood pressure control, (C) cholesterol management, and (S) smoking screening and cessation intervention. Study design: The study used a stepped-wedge cluster RCT design with 4 intervention waves. Data were extracted for 13 quarters between January 1, 2015 and March 31, 2018, which encompassed the control, intervention, and follow-up periods for all waves, and analyzed in 2019. Setting/participants: A total of 257 small independent primary care practices in New York City were randomized into 1 of 4 waves. Intervention: The intervention consisted of practice facilitators conducting at least 13 practice visits over 1 year, focused on capacity building and implementing system and workflow changes to meet cardiovascular disease care guidelines. Main outcome measures: The main outcomes were the Million Hearts’ ABCS measures. Two additional measures were created: (1) proportion of tobacco users who received a cessation intervention (smokers counseled) and (2) a composite measure that assessed the proportion of patients meeting treatment targets for A, B, and C (ABC composite). Results: The S measure improved when comparing follow-up with the control period (incidence rate ratio=1.152, 95% CI=1.072, 1.238, p<0.001) and when comparing follow-up with intervention (incidence rate ratio=1.060, 95% CI=1.013, 1.109, p=0.007). Smokers counseled improved when comparing the intervention period with control (incidence rate ratio=1.121, 95% CI=1.037, 1.211, p=0.002). Conclusions: Increasing the impact of practice facilitation programs that target multiple risk factors may require a longer, more intense intervention and greater attention to external policy and practice context. Trial registration: This study is registered at www.clinicaltrials.gov NCT02646488.
KW - Aspirin/therapeutic use
KW - Blood Pressure/physiology
KW - Cardiovascular Diseases/prevention & control
KW - Cholesterol/analysis
KW - Goals
KW - Guideline Adherence/organization & administration
KW - Health Behavior
KW - Heart Disease Risk Factors
KW - Humans
KW - New York City
KW - Smoking Cessation/statistics & numerical data
UR - http://www.scopus.com/inward/record.url?scp=85079664984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079664984&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2019.12.013
DO - 10.1016/j.amepre.2019.12.013
M3 - Article
C2 - 32067871
AN - SCOPUS:85079664984
SN - 0749-3797
VL - 58
SP - 683
EP - 690
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 5
ER -